Article

Cytel Announces East Alloy

Cytel Inc. has announced the launch of East Alloy, a new platform that is a web-native extension of Cytel’s East software that builds on the company's delivering of Bayesian tools and engines to the pharmaceutical industry for clinical trials.

For more information, click here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer
August 27th 2025

Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer

Don Tracy, Associate Editor
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
August 27th 2025

ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains

Andy Studna, Senior Editor
© JHVEPhoto - © JHVEPhoto - stock.adobe.com
August 27th 2025

FDA Expands Transparency With Daily Adverse Event Reporting

Andy Studna, Senior Editor
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
August 27th 2025

ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials

Andy Studna, Senior Editor
Dynavax Technologies’ Investigational Shingles Vaccine Achieves Complete Antibody Response in Phase I/II Shingles Trial
August 27th 2025

Dynavax Technologies’ Investigational Shingles Vaccine Achieves Complete Antibody Response in Phase I/II Shingles Trial

Don Tracy, Associate Editor
© WESTOCK - © WESTOCK - stock.adobe.com
August 27th 2025

Supreme Court Upholds NIH Funding Cuts Affecting DEI in Clinical Research

Andy Studna, Senior Editor
© 2025 MJH Life Sciences

All rights reserved.